Published in Chin J Cancer on March 01, 2011
Current State of Animal (Mouse) Modeling in Melanoma Research. Cancer Growth Metastasis (2015) 0.91
Modeling Melanoma In Vitro and In Vivo. Healthcare (Basel) (2013) 0.85
Melanoma central nervous system metastases: current approaches, challenges, and opportunities. Pigment Cell Melanoma Res (2016) 0.81
Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models. Oncoimmunology (2012) 0.80
A murine model for the development of melanocytic nevi and their progression to melanoma. Mol Carcinog (2015) 0.77
Genetically engineered mouse models of melanoma. Cancer (2017) 0.75
Resistance mechanisms to genetic suppression of mutant NRAS in melanoma. Melanoma Res (2017) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med (2010) 36.57
A system for stable expression of short interfering RNAs in mammalian cells. Science (2002) 35.21
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell (2010) 17.48
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell (1997) 12.41
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet (2003) 12.16
Role of the INK4a locus in tumor suppression and cell mortality. Cell (1996) 11.41
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell (1998) 8.99
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet (2009) 7.81
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell (1995) 7.34
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A (1996) 5.93
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet (2003) 5.82
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A (1994) 5.71
Signal transduction through MAP kinase cascades. Adv Cancer Res (1998) 5.65
A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell (1993) 4.97
Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell (2009) 4.76
Inducible gene targeting in mice using the Cre/lox system. Methods (1998) 4.61
Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature (1984) 4.27
Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev (2006) 4.24
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev (2009) 4.15
Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem (2005) 3.88
A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci U S A (1995) 3.80
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev (1998) 3.68
Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. J Virol (1993) 3.46
The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology (1998) 3.35
Functional studies of the kidney of living animals using multicolor two-photon microscopy. Am J Physiol Cell Physiol (2002) 3.09
The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology (1998) 2.96
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet (2003) 2.67
Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J (1994) 2.57
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev (1997) 2.47
Neonatal sunburn and melanoma in mice. Nature (2001) 2.25
Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control (2001) 2.21
Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst (1976) 2.09
TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor. Development (1992) 2.05
A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. Proc Natl Acad Sci U S A (1994) 1.99
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev (2007) 1.98
Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene (1999) 1.92
Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat Genet (2005) 1.90
Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res (2005) 1.84
Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol (2001) 1.73
The INK4 family of cell cycle inhibitors in cancer. Oncogene (1999) 1.70
A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors. Proc Natl Acad Sci U S A (2008) 1.70
Inducible gene expression systems for higher eukaryotic cells. Curr Opin Biotechnol (1994) 1.69
ras oncogenes: their role in neoplasia. Eur J Clin Invest (1990) 1.68
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice. Oncogene (2009) 1.66
ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc Natl Acad Sci U S A (2007) 1.61
Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res (1988) 1.60
The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci (1998) 1.59
Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res (2010) 1.50
Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. J Virol (2001) 1.41
Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development. Proc Natl Acad Sci U S A (2000) 1.41
Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Oncogene (2010) 1.36
An RCAS-TVA-based approach to designer mouse models. Mamm Genome (2002) 1.36
Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo. Cancer Res (2005) 1.35
Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc Natl Acad Sci U S A (2003) 1.32
Insights into cancer from transgenic mouse models. J Pathol (1999) 1.31
Sun exposure and skin cancer. Australas J Dermatol (1997) 1.29
Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo. Oncogene (2003) 1.29
Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res (2002) 1.24
Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis. Cancer Res (2008) 1.19
Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A. Cancer Res (1976) 1.15
Molecular events in melanoma development and progression. Front Biosci (1998) 1.10
Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis. Pigment Cell Melanoma Res (2010) 1.10
Narrative review: BRAF opens the door for therapeutic advances in melanoma. Ann Intern Med (2010) 1.05
Molecular genetics of familial cutaneous melanoma. J Clin Oncol (1998) 1.05
Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice. Cancer Res (2006) 1.03
A novel mouse model for de novo Melanoma. Cancer Res (2010) 1.03
Incidence, risk factors and prevention of melanoma. Eur J Cancer (1998) 1.01
WNT1 and WNT3a promote expansion of melanocytes through distinct modes of action. Pigment Cell Res (2005) 1.00
A model for studying megakaryocyte development and biology. Proc Natl Acad Sci U S A (1999) 1.00
Somatic p16(INK4a) loss accelerates melanomagenesis. Oncogene (2010) 0.99
Splenic regulation of the clinical appearance of small tumors. J Immunol (1975) 0.99
Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice. Cancer Res (2000) 0.99
From UVs to metastases: modeling melanoma initiation and progression in the mouse. J Invest Dermatol (2008) 0.97
Delivery of short hairpin RNA sequences by using a replication-competent avian retroviral vector. J Virol (2004) 0.97
Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res (2001) 0.97
A mouse model of melanoma driven by oncogenic KRAS. Cancer Res (2010) 0.96
A new defective retroviral vector system based on the Bryan strain of Rous sarcoma virus. Virology (1993) 0.96
Mechanism of 7,12-dimethylbenz[a]anthracene-induced immunotoxicity: role of metabolic activation at the target organ. Jpn J Pharmacol (2001) 0.96
Animal models of melanoma: recent advances and future prospects. Adv Cancer Res (2000) 0.96
Mouse models for melanoma: a personal perspective. Exp Dermatol (2009) 0.95
Tumor suppressor mutations in mice: the next generation. Curr Opin Genet Dev (1998) 0.94
Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation. Am J Pathol (2006) 0.91
Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice. Cancer Res (2007) 0.90
Malignant melanoma: prognostic indicators. Mayo Clin Proc (1997) 0.88
Neonatal ultraviolet radiation exposure is critical for malignant melanoma induction in pigmented Tpras transgenic mice. J Invest Dermatol (2005) 0.86
Genes involved in melanoma: an overview of INK4a and other loci. Melanoma Res (1999) 0.86
Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice. Pigment Cell Melanoma Res (2010) 0.84
Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma. Am J Pathol (2005) 0.82
Topical application of dimethylbenz[a]anthracene results in the generation of multiple melanocytic nevi in C3H/HeN mice. Toxicol Appl Pharmacol (2004) 0.81
Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice. Cancer Res (1993) 0.80
Cooperativity of Cdk4R24C and Ras in melanoma development. Cell Cycle (2010) 0.79
Ultraviolet radiation induces both full activation of ret kinase and malignant melanocytic tumor promotion in RFP-RET-transgenic mice. J Invest Dermatol (2000) 0.78
Xenograft model systems for human melanoma. Mol Med Today (1996) 0.76
Tumor immunology with particular reference to malignant melanoma. Int J Dermatol (1975) 0.76
Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol Cell Biol (2005) 2.00
Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma. Cancer Res (2009) 1.44
IDH1 and IDH2 mutations in gliomas. Curr Neurol Neurosci Rep (2013) 1.32
APC inhibits ERK pathway activation and cellular proliferation induced by RAS. J Cell Sci (2006) 1.09
Delivery of short hairpin RNA sequences by using a replication-competent avian retroviral vector. J Virol (2004) 0.97
Akt signaling is required for glioblastoma maintenance in vivo. Am J Cancer Res (2011) 0.94
Inhibition of Marek's disease virus replication by retroviral vector-based RNA interference. Virology (2008) 0.89
Inhibition of avian leukosis virus replication by vector-based RNA interference. Virology (2007) 0.89
Met amplification and tumor progression in Cdkn2a-deficient melanocytes. Pigment Cell Melanoma Res (2009) 0.84
Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice. Pigment Cell Melanoma Res (2010) 0.84
Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions. J Invest Dermatol (2012) 0.83
Ink4a/Arf loss promotes tumor recurrence following Ras inhibition. Neuro Oncol (2011) 0.83
Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis. Melanoma Res (2017) 0.75
Resistance mechanisms to genetic suppression of mutant NRAS in melanoma. Melanoma Res (2017) 0.75